EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 377 filers reported holding EXELIXIS INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $1,260 | +734.4% | 52,560 | +574.5% | 0.00% | – |
Q1 2023 | $151 | -99.9% | 7,792 | -50.6% | 0.00% | – |
Q3 2022 | $247,000 | -86.1% | 15,775 | -81.5% | 0.00% | -100.0% |
Q2 2022 | $1,777,000 | -22.0% | 85,373 | -15.0% | 0.00% | 0.0% |
Q1 2022 | $2,277,000 | +283.3% | 100,457 | +208.9% | 0.00% | +100.0% |
Q4 2021 | $594,000 | +21.2% | 32,522 | +23.5% | 0.00% | – |
Q3 2021 | $490,000 | -2.2% | 26,340 | -4.4% | 0.00% | – |
Q2 2021 | $501,000 | – | 27,540 | +1554.1% | 0.00% | – |
Q1 2021 | $0 | -100.0% | 1,665 | -94.3% | 0.00% | -100.0% |
Q4 2020 | $582,000 | +97.3% | 29,000 | +139.6% | 0.00% | – |
Q3 2020 | $295,000 | +37.2% | 12,103 | -3.3% | 0.00% | – |
Q1 2020 | $215,000 | -68.2% | 12,519 | -67.4% | 0.00% | -100.0% |
Q4 2019 | $677,000 | +450.4% | 38,454 | +452.3% | 0.00% | – |
Q3 2019 | $123,000 | -8.2% | 6,962 | +10.7% | 0.00% | – |
Q2 2019 | $134,000 | -2.9% | 6,289 | -19.7% | 0.00% | – |
Q3 2018 | $138,000 | +1625.0% | 7,836 | +1859.0% | 0.00% | – |
Q2 2018 | $8,000 | -65.2% | 400 | -48.3% | 0.00% | -100.0% |
Q4 2017 | $23,000 | -96.4% | 773 | -97.1% | 0.00% | -96.2% |
Q3 2017 | $641,000 | -15.3% | 26,477 | -13.9% | 0.03% | -21.2% |
Q2 2017 | $757,000 | +3685.0% | 30,738 | +2130.6% | 0.03% | +3200.0% |
Q4 2016 | $20,000 | -94.8% | 1,378 | -95.4% | 0.00% | -96.2% |
Q3 2016 | $386,000 | +565.5% | 30,210 | +105.5% | 0.03% | +420.0% |
Q1 2016 | $58,000 | – | 14,703 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
Signition LP | 84,120 | $1,798,000,000 | 1.18% |
Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |